Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe change consists only of a version revision tag, updating from v3.4.0 to v3.4.1, with no changes to study content or page functionality. To avoid being alert by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor backend update with no visible changes to study content or navigation.SummaryDifference0.0%

- Check27 days agoChange DetectedResults status in the study record changed from 'No Results Posted' to 'Results Submitted'. This indicates that the trial results have been submitted and will be posted.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No substantive content changes to study details or eligibility criteria are evident.SummaryDifference0.0%

- Check62 days agoChange DetectedA dedicated Locations section was added listing study sites in Arizona and Minnesota, and the former separate Arizona Locations and Minnesota Locations subsections were removed.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.